Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

OWL

OWL Stock Struggles to Reach 52-Week High Despite Recent Surge

Blue Owl Capital stock is trading -24.42% below its average target price of $22.04 after marking a 2.1% during today's afternoon session. Analysts are giving the Large-Cap Asset Management company an average rating of buy and target prices ranging from $18.0 to $28.0 per share.

Blue Owl Capital has an average level of shares sold short, at 8.0% of its total share float. The stock's short ratio (also called days to cover) is 4.79. At 0.04%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation.

Institutional investors own 96.0% of Blue Owl Capital's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Blue Owl Capital

Date Reported Holder Percentage Shares Value
2025-06-30 Capital World Investors 13% 84,073,355 $1,400,241,785
2025-06-30 Vanguard Group Inc 10% 62,948,362 $1,048,405,012
2025-06-30 Capital International Investors 9% 60,584,461 $1,009,034,239
2025-06-30 Blackrock Inc. 7% 45,217,166 $753,091,930
2025-06-30 FMR, LLC 7% 43,873,007 $730,704,961
2025-06-30 ICONIQ Capital, LLC 5% 33,500,000 $557,942,523
2025-06-30 Bank of America Corporation 3% 20,812,929 $346,639,346
2025-06-30 Morgan Stanley 2% 13,504,045 $224,909,878
2025-06-30 Geode Capital Management, LLC 2% 10,293,279 $171,434,568
2025-06-30 JPMORGAN CHASE & CO 2% 9,904,618 $164,961,419
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS